BACKGROUND: Stroke may occur during hospital admission (in-hospital stroke). Although patients with in-hospital stroke are potentially good candidates for reperfusion therapy, they often do not receive treatment as rapidly as expected. AIMS: We investigated the effect of a code stroke program for in-hospital stroke, which included the use of computerized physician order entry, specific evaluation and treatment protocols for in-hospital stroke patients, and regular education of medical staffs. METHODS: We implemented the program in the cardiology and cardiovascular surgery departments/wards (target-ward group) in November 2008. We compared time intervals from symptom onset to evaluation and reperfusion treatment before and after program im...
Objective: To reduce door-to-angiographic reperfusion (DTR) time to 120 minutes for patients present...
Explaining the risks and benefits of recombinant tissue-plasminogen activator (rtPA) to eligible pat...
Introduction: Stroke is a development of an acute focal neurological deficit with an ischemic or hem...
Introduction: Acute strokes in the inpatient setting comprise 6-15% of all strokes annually and are ...
Background: The need for rapid evaluation and treatment of acute stroke patients has been well docum...
Objective: Ischemic strokes cause significant morbidity and mortality. Treatment with tissue plasmin...
Background and Purpose—An effective stroke code system that can expedite rapid thrombolytic treatmen...
Introduction: Inpatient strokes have a higher mortality risk and longer length of stay compared to c...
Introduction: In-hospital strokes account for 2-17% of all stroke patients. Mobilization of resource...
CONTEXT: Although tissue plasminogen activator (tPA) is an effective treatment for stroke patients, ...
BACKGROUND AND PURPOSE: An effective stroke code system that can expedite rapid thrombolytic treatme...
Introduction: Delays in door to skin puncture time for patients with ischemic stroke are associated ...
Background and Purpose: Several emerging stroke therapies require patients to be treated within seve...
BACKGROUND: Patients may experience stroke while being admitted to the hospital (in-hospital stroke ...
Background and Purpose—Stroke recovery critically depends on timely reperfusion. In July 2003, we se...
Objective: To reduce door-to-angiographic reperfusion (DTR) time to 120 minutes for patients present...
Explaining the risks and benefits of recombinant tissue-plasminogen activator (rtPA) to eligible pat...
Introduction: Stroke is a development of an acute focal neurological deficit with an ischemic or hem...
Introduction: Acute strokes in the inpatient setting comprise 6-15% of all strokes annually and are ...
Background: The need for rapid evaluation and treatment of acute stroke patients has been well docum...
Objective: Ischemic strokes cause significant morbidity and mortality. Treatment with tissue plasmin...
Background and Purpose—An effective stroke code system that can expedite rapid thrombolytic treatmen...
Introduction: Inpatient strokes have a higher mortality risk and longer length of stay compared to c...
Introduction: In-hospital strokes account for 2-17% of all stroke patients. Mobilization of resource...
CONTEXT: Although tissue plasminogen activator (tPA) is an effective treatment for stroke patients, ...
BACKGROUND AND PURPOSE: An effective stroke code system that can expedite rapid thrombolytic treatme...
Introduction: Delays in door to skin puncture time for patients with ischemic stroke are associated ...
Background and Purpose: Several emerging stroke therapies require patients to be treated within seve...
BACKGROUND: Patients may experience stroke while being admitted to the hospital (in-hospital stroke ...
Background and Purpose—Stroke recovery critically depends on timely reperfusion. In July 2003, we se...
Objective: To reduce door-to-angiographic reperfusion (DTR) time to 120 minutes for patients present...
Explaining the risks and benefits of recombinant tissue-plasminogen activator (rtPA) to eligible pat...
Introduction: Stroke is a development of an acute focal neurological deficit with an ischemic or hem...